Sylvester Comprehensive Cancer Center (Sylvester) has joined the BPDCN International registry. It delivers leading-edge patient care by the region’s best doctors, powered by the groundbreaking research and medical education of the University of Miami, Leonard M. Miller School of Medicine. As South Florida’s only recognized Cancer Center of Excellence, Sylvester is a vital component supporting the local community.
Since the program’s inception in 2015, Sylvester has been recognized as a Cancer Center of Excellence, meeting the rating standards created by a joint committee of members from the Florida Cancer Control and Research Advisory Council and the Biomedical Research Advisory Council, two advisory groups mandated by the Florida Legislature. The values of Sylvester are excellence, compassion, respect and discovery
About BPDCN International Registry
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy discovered in 2008. The International Registry is a multicenter, international prospective and retrospective registry with the aim of collecting data of patients with a diagnosis of BPDCN globally. If you think your hospital would benefit from partnership in this registry, please contact Dr.Astghik Voskanyan ([email protected]).
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.